MHCombiotic

MHCombiotic Inc. is a biotechnology company. The company is dedicated to addressing the global challenge of antimicrobial resistance (AMR) and life-threatening infections by developing safe, effective, and scalable alternatives to antibiotics. The core technology, the Combiotic™ Platform, uses a synergistic combination of plant-based small molecules and inorganic salts. This platform offers superior antibacterial, anti-inflammatory, and anti-biofilm properties, specifically targeting infections where biofilms hinder healing. MHCombiotic has screened over 18,000 formulations in the wet lab and millions more using AI to identify optimized candidates with strong preclinical and translational potential.The company is led by an award-winning team and aims to reduce the global burden of AMR by delivering next-generation antimicrobials across Wound Care, Respiratory, and systemic infection markets.